gastroesophageal reflux disease (GERD) Segmentation: Document how Swiss general practitioners (GPs) allocate their GERD patients to the three GERD patient segments
Study identifier:NIS-GCH-NEX-2007/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
GERD Segmentation: Document how Swiss GPs allocate their GERD patients to the three GERD patient segments
Medical condition
GERD
Phase
-
Healthy volunteers
No
Study drug
-
Sex
All
Actual Enrollment
2912
Study type
Observational
Age
12 Years +
Date
Study Start Date: 01 Feb 2008
Primary Completion Date: 01 Aug 2008
Study Completion Date: 01 Aug 2008
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Jan 2015 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| Treated GERD pts Previously diagnosed GERD patients on treatment in Switzerland | - |
